000 01507 a2200433 4500
005 20250516210046.0
264 0 _c20150720
008 201507s 0 0 eng d
022 _a1536-3694
024 7 _a10.1097/FTD.0000000000000084
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBleyzac, Nathalie
245 0 0 _aPharmacokinetic drug interaction between cyclosporine and imatinib in bone marrow transplant children and model-based reappraisal of imatinib drug interaction profile.
_h[electronic resource]
260 _bTherapeutic drug monitoring
_cDec 2014
300 _a724-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aBenzamides
_xblood
650 0 4 _aBone Marrow Transplantation
_xadverse effects
650 0 4 _aChild
650 0 4 _aCyclosporine
_xblood
650 0 4 _aDrug Interactions
_xphysiology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImatinib Mesylate
650 0 4 _aImmunosuppressive Agents
_xblood
650 0 4 _aMale
650 0 4 _aModels, Biological
650 0 4 _aPiperazines
_xblood
650 0 4 _aProtein Kinase Inhibitors
_xblood
650 0 4 _aPyrimidines
_xblood
650 0 4 _aYoung Adult
700 1 _aKebaili, Kamila
700 1 _aMialou, Valérie
700 1 _aBertrand, Yves
700 1 _aGoutelle, Sylvain
773 0 _tTherapeutic drug monitoring
_gvol. 36
_gno. 6
_gp. 724-9
856 4 0 _uhttps://doi.org/10.1097/FTD.0000000000000084
_zAvailable from publisher's website
999 _c23743984
_d23743984